TEXAS CAPITAL BANCSHARES INC/TX (TCBI): what the price assumes

In the published model solve dated 2026-Q2, anchored at $100.05, TEXAS CAPITAL BANCSHARES INC/TX (TCBI) is priced for more than 13.2% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-11.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/TCBI

Headline

FieldValue
TickerTCBI
CompanyTEXAS CAPITAL BANCSHARES INC/TX
Sector / IndustryFinancial Services
Current price$100.05/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Price-to-book1.30x
Return on equity now9.4%

The implied return on book is non-physical at this price-to-book and is suppressed as misleading. The price sits beyond a 11.7% return on equity sustained for 40 years and is not resolvable as a sustainable-ROE point. The rarity read below is the honest signal.

Solve inputs: computed at a 11.1% cost of equity; ROE searched up to the 11.7% ROE ceiling.

Reconcile: at the x-ray's 9.3% required return this reads ~10.8%; the models below use their own rates.

How unusual the bet is: n/a

ReferenceValue
vs own history+1.46σ
cohort percentile (of 166 peers)45
sustained it ~10 years at this level66%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.08x3expensive
Earnings1.20x1expensive
Relative0
Growth0

Families that justify the price: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.7%); the inversion above states its own rate.

Per-Model Detail (n=4)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthno
Bank Fair Value (P/TBV)$90.201.11xyesTBVPS $82.78 × 1.09x (ROE (TTM) 10.0% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption), credit 1.09% allowance/loans → ×0.93)
Relative ValuationRelativenoP/E 10x (static sector reference · 2026-04), scenarios: 8.3x / 10.0x / 11.7x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$89.461.12xyesBV/sh $82.78, ROE (TTM) 10.0%, ke 9.3%
Two-Stage Excess ReturnAsset$92.891.08xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowthnoRev $1.1B, growth 10% (input: historical growth; tapered), Terminal P/S: 3.5x / 4.2x / 4.9x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelativenoEPS $7.68, growth 35% (input: historical EPS growth), PEG=0.35 (Undervalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAssetno
Graham NumberAsset$119.600.84xyes√(22.5 × EPS $7.68 × BVPS $82.78) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsnoEPS $7.68 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelativeno
PEG Fair ValueRelativenoEPS $7.68 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$83.031.20xyesEPS $7.68 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

The issuer is a funded financial business. Debt, interest, and cash flows are operating inputs, so industrial EV, net-debt, WACC, and free-cash-flow lenses do not apply; value the common-equity claim with book, earnings, capital, and payout economics.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Texas Capital (consolidated bank)financialequity1.3B reported-currencywithheldunresolved standalone equity facts required

No unit-level total common-equity value is stated. Each financial unit requires supported standalone common equity, normalized earnings, capital adequacy, and payout capacity. Consolidated debt, interest, and cash are operating balances, not an enterprise-to-equity bridge; company-level book, earnings, capital, and payout lenses remain the coherent cross-checks.

Solvency

FieldValue
Share count CAGR (buyback)-3.5%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

The standard knock on Texas Capital is that it earns less on its capital than that capital costs: recent return on equity runs about 9.4% against a cost of equity north of 11%, and a bank that persistently under-earns its capital cost deserves to trade at a discount to book. That is the fear worth examining first, because the recent data undermines it quarter by quarter. First-quarter 2026 adjusted EPS rose 72% year over year to $1.58 on revenue growth of 16% to $324 million, with fee income reaching a record $58.8 million on strong investment banking and treasury performance. The under-earning bank is becoming a differently shaped company, and the income statement is where the reshaping shows first.

The shape matters as much as the pace. The old Texas Capital was a spread lender; the emerging one layers fee businesses on top, and the 10-K describes the deposit franchise the fees ride on, built through development of long-term customer relationships, with a significant focus on treasury management products [FY2025 10-K, accession 0001077428-26-000010]. Investment banking and treasury fees are capital-light revenue: they raise return on equity without raising the balance sheet, which is precisely the lever a bank needs when the complaint is return on capital. Management's confidence has a concrete marker: the board initiated the company's first quarterly dividend at $0.20 per share, and the share count has fallen about 3.4% a year over the past four years, so capital is being returned on both channels while earnings ramp.

What the price demands is not heroic. The market pays about 1.4 times book, which assumes returns on equity around 12.5% sustained long-term, a level our comparison work reads as within reach of what the bank has earned before and broadly consistent with plausible growth; roughly two-thirds of banks that reach that return level held it for a decade. The sell side has been marking the trajectory up, with JPMorgan raising its target to $105 and RBC to $114 in April 2026, and full-year guidance of mid- to high-single-digit revenue growth was left unchanged even after the strong first quarter. If the fee engine keeps pulling return on equity toward the assumed 12.5%, the stock is a bank re-rating story caught halfway through the re-rate.

Bear Case

The structural question sits in the funding stack and the loan book, not the earnings trend. Texas Capital's own filing states the caution plainly: liquidity is managed for normal and financially stressed conditions, but there is no assurance that the Company will be able to make new loans, meet ongoing funding commitments to borrowers, or replace maturing deposits and advances as necessary under all possible circumstances [FY2025 10-K, accession 0001077428-26-000010]. Every bank carries that boilerplate; it bites harder at a commercial-focused bank whose deposit base skews toward business treasury balances that move faster and in larger blocks than retail savings, and which supplements them through brokered channels, as the same filing notes. Commercial depositors are professionals. In a stress window, professional money leaves first.

The asset side carries its own concentrations. The company held $6.2 billion in shared national credits as of December 31, 2025 [FY2025 10-K, accession 0001077428-26-000010], syndicated loans where Texas Capital is one lender among many and does not control the workout when a credit sours. The commercial real estate book, disclosed by property type in the filing, adds cyclical exposure that includes residential builder and developer loans whose repayment depends on, in the filing's words, the borrower's ability to obtain permanent financing and consumer demand. All of it is concentrated in one state's economy. Texas has been a good state to concentrate in; concentration is still concentration when the cycle turns.

Then there is what the price already assumes. At about 1.4 times book, the market needs a roughly 12.5% return on equity sustained for something like twenty-six years before normalizing, while the bank has recently earned about 9.4%. The gap between assumed and demonstrated is the bear case in one line: if the fee-driven improvement stalls and return on equity settles back at the recent level, below the cost of equity, the price-to-book the stock supports compresses toward and below one, which is a long fall from 1.4 times. The first-quarter surge leaned on record investment banking and treasury fees, and fee income of that kind is the most cyclical revenue a bank produces; guidance already leans on a December rate cut to a 3.5% Fed funds rate to get there. One weak capital-markets stretch and the re-rating story loses its proof point while the balance-sheet risks stay exactly where they were.

Valuation

Read the price off the book multiple, as bank prices should be read. At $102.33 (July 10, 2026), the market pays about 1.4 times book against $80.85 of book value per share, and that multiple unwinds to an assumed return on equity of roughly 12.5%, the top tier of the comparison panel, held for approximately twenty-six years before fading to normal, equivalent to about 13.7% in perpetuity. The bank has recently earned about 9.4%, so the price requires improvement, not merely persistence. Three countable facts calibrate how demanding that is: the assumed return is within reach of the bank's own past record, the book multiple sits in the upper half of the peer group, and about 64% of banks that reached this return level sustained it for a decade. Our framework reads the whole assumption as within range, a plausible bet rather than a stretched one.

The method families agree with that read to an unusual degree. Asset-based, peer-multiple, and growth-anchored approaches all land within roughly 15% of the price, with the price slightly above their central estimates, while the earnings-power reads sit modestly above the price. No family calls the stock expensive outright, and none screams cheap; the disagreement here is narrow, which itself is information. At $7.43 of trailing EPS the stock trades near 13.8 times earnings against a 10 times sector median, and the premium over the sector is the market's advance credit for the fee transformation, the investment banking and treasury businesses that produced record fee income of $58.8 million in the first quarter.

Capital and payout carry the balance-sheet story, since deposits are funding rather than leverage. The share count has declined about 3.4% a year over four years, and the board initiated the company's first common dividend at $0.20 per quarter, so the payout machinery now runs on both channels against a growing earnings base. On the asset side, the loan book includes $6.2 billion of shared national credits and a commercial real estate portfolio disclosed by property type [FY2025 10-K, accession 0001077428-26-000010], the concentrations any downside scenario would run through. The valuation question is one variable wide: whether return on equity closes the gap from 9.4% toward the 12.5% the price assumes. Each quarterly print is a direct reading on it.

Catalysts

The second-quarter earnings report, due on the company's usual mid-July cadence, is the immediate event. The first quarter set a demanding comparison base, with adjusted EPS of $1.58 up 72% year over year, revenue of $324 million up 16%, and record fee income of $58.8 million from investment banking and treasury. The market will read the print for one thing above all: whether fee income holds near record levels or proves to have been a capital-markets quarter. Full-year 2026 guidance was left unchanged at mid- to high-single-digit total revenue growth, built on an assumption of one more rate cut with Fed funds at 3.5% by year-end, so the December Fed meeting is a macro catalyst wired directly into management's own math.

Capital returns add two running threads. The board approved the initiation of a quarterly common dividend of $0.20 per share, a first for the company and a signal about the durability management assigns to the earnings ramp; the declaration cadence and any early increase would extend that signal. Buybacks have been reducing the share count around 3.4% annually, and the pace disclosed each quarter compounds the per-share story.

Sell-side sentiment has been drifting up: JPMorgan raised its price target to $105 from $100 and RBC Capital to $114 from $110 in April 2026. With the stock at $102.33, the market has already caught most of those targets, which puts the burden of the next leg on reported numbers rather than rating changes, and puts particular weight on the return-on-equity trajectory the valuation depends on.

Peer Cohorts (Per Segment, With Filing Citations)

Texas Capital (consolidated bank) (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Texas Capital Q1 2026 results, April 2026 · Texas Capital dividend announcement, 2026 · analyst updates, April 2026 · Texas Capital Q1 2026 earnings call, April 2026

View the full interactive TCBI report on boothcheck